Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citation:


Bakhtiyarova K.Z., Boyko A.N., Vlasov Y.V., Goncharova Z.A., Davydovskaya M.V., Zakharova M.N., Malkova N.A., Nilov A.I., Sivertseva S.A., Spirin N.N., Totolyan N.A., Khabirov F.A., Shumilina M.V. Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(3):93-99. (In Russ.) https://doi.org/10.14412/2074-2711-2020-3-93-99

Views: 38


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)